Gil Beyen founded TiGenix NV. Presently, Mr. Beyen is Chief Executive Officer & Director at ERYTech Pharma SA. Mr. Beyen is also Manager at Gil Beyen BVBA, Manager of Axxis V&C BVBA and Commissioner of Vlaams Instituut voor Biotechnologie - Flanders Institute and on the board of 5 other companies.
He previously was Head-Life Sciences Division at Arthur D. Little, Inc. and Head-Life Sciences Division at Arthur D. Little Benelux NV (a subsidiary of Arthur D. Little, Inc.) and MD, Executive Director & Chief Business Officer at TiGenix NV.
Mr. Beyen received an MBA from The University of Chicago, a graduate degree from Université Catholique de Louvain and a graduate degree from Katholieke Universiteit Leuven.